AzTrials
AzTrials

Road Traffic Injury PreventionNCT02120742

The Impact Of Text Message (SMS) Reminders On Helmet Use Among Motorcycle Drivers In Dar Es Salaam, Tanzania

A study testing SMS message reminder in people with Road Traffic Injury Prevention and Helmet Use, run by Amend at 1 site in Tanzania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study seeks to evaluate the impact of a text-message (SMS) program delivered to motorcycle drivers in Dar es Salaam, Tanzania. The SMS program, delivered by nonprofit Amend, sends daily reminders to motorcycle drivers to remind them to wear their helmets. Read more about this study

Who is it for?
Ages 18 years and older, men onlyHealthy volunteers can take part
What is being tested?
SMS message reminder
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
391 participants
Where
1 siteTanzania
Study dates
Apr 2014to Sep 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 or older
  • Must own a cell phone with text-message features
  • Must demonstrate ability to retrieve and read text-messages
  • Must have access to a helmet.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Tanzania1 site
  • Muhimbili University of Health and Allied Sciences

    Dar es Salaam, Upanga West, 65001

Other trials in Tanzania

About this study

This study seeks to evaluate the impact of a text-message (SMS) program delivered to motorcycle drivers in Dar es Salaam, Tanzania. The SMS program, delivered by nonprofit Amend, sends daily reminders to motorcycle drivers to remind them to wear their helmets. In this study, the investigators will conduct a randomized controlled trial to see if this program leads to increased helmet use over time. The investigators will recruit between 350-400 motorcycle drivers to receive the text program. The investigators will obtain each of their cell phone numbers, and the participants will be split into three groups. The first group will receive reminders framed as social norming (ie "Most of your peers wear helmets"). The second group will receive reminders framed as fear appeals (ie "Not wearing your helmet increases your chance of dying in an accident"). The third group will act as the control and receive texts that relate to general road safety, but not helmet use. All groups will receive the same general road safety information being delivered to the control arm. The purpose of sending different types of reminders is to assess which type of messages are more likely to cause a motorcycle driver to regularly wear their helmet. The investigators will survey the participants at the initiation of the study and after weeks 3 and 6 during the study, asking about their helmet use. This will be a short survey, and any personal information gathered during the study (ie, phone numbers), will be securely stored so as to protect their privacy.

Being tested
SMS message reminder
Keywords
Road traffic injury prevention, Helmet use, mHealth intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SMS message reminderBehavioural

    SMS texts will be delivered to study participants over a 6-week period.

Study groups in NCT02120742
Study groupRoleWhat they receive
Social NormingExperimentalThe first group will receive SMS message reminders framed as social norming (ie "Most of your peers wear helmets").
Receives: Behavioral: SMS message reminder
Fear AppealExperimentalThe second group will receive SMS message reminders framed as fear appeals (ie "Not wearing your helmet increases your chance of dying in an accident").
Receives: Behavioral: SMS message reminder
ControlPlacebo comparatorThe third group will act as the control and receive texts that relate to general road safety, but not helmet use.
Receives: Behavioral: SMS message reminder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported adherence to helmet use

    The primary outcome of the study will be self-reported adherence to helmet use as measured by the proportion of participants who wear their helmet on all trips

    Measured: Midpoint of study (3 weeks)

  2. Self-reported adherence to helmet use

    The primary outcome of the study will be self-reported adherence to helmet use as measured by the proportion of participants who wear their helmet on all trips

    Measured: Endpoint of study (6 weeks)

Secondary outcomes (1)
  1. Attitude change

    A secondary outcome will be participants' attitudes toward helmet use and the SMS reminder platform, as measured by an open-ended survey at the end of the study.

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Apr 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionJun 2014
  4. Study completionSep 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
391 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02120742
Sponsor's protocol ID
D14103
Status last verified
Sep 2015
First submitted
19 Apr 2014
Last updated
30 Sep 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Campbell B, Heitner J, Amos Mwelelo P, Fogel A, Mujumdar V, Adams LV, Boniface R, Su Y. Impact of SMS Text Messaging Reminders on Helmet Use Among Motorcycle Drivers in Dar es Salaam, Tanzania: Randomized Controlled Trial. J Med Internet Res. 2022 Apr 7;24(4):e27387. doi: 10.2196/27387.

    PubMed 35389364

Questions about this trial

What is this clinical trial studying?

A study testing SMS message reminder in people with Road Traffic Injury Prevention and Helmet Use, run by Amend at 1 site in Tanzania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Tanzania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported adherence to helmet use (time frame: Midpoint of study (3 weeks)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02120742, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in